Tuesday, July 16, 2019

Strides Pharma Science Shares Drop On US Drug Regulator's Warning Letter

US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.

from NDTV Profit - Latest https://ift.tt/2GsIzEz
via

No comments:

Post a Comment